Search Results
Your search for

Johnson & Johnson

yielded 1204 results

Johnson & Johnson will pay for $4.69 billion talc verdict one way or the other

Last July, Johnson & Johnson was hit with a staggering $4.69 billion verdict – one of the largest jury awards in the country – over claims that its Johnson’s Baby Powder and other talcum powder products contain asbestos – a known carcinogen – and contributed to the ovarian cancer diagnoses of 22 women. The news sent the company’s stock into its biggest annual share loss in a decade. But the company may never pay a dime of that verdict. The consumer health care giant is appealing the massive verdict. Its chances of seeing the award slashed or even stricken completely ... Read More

Local newspaper covers Beasley Allen’s past and future battles with Johnson & Johnson over talc

In a recent article, the Montgomery Advertiser features Montgomery firm Beasley Allen and its ongoing legal battles with Johnson & Johnson over cases related to the company’s talcum powder products and their link to ovarian cancer. In 2016, the firm had success in Missouri state court leading a joint lawsuit filed on behalf of 64 women, of which three women’s suits went to trial. Three separate juries found in favor of the plaintiffs, who alleged that the company’s talc-containing products contributed to their ovarian cancer. In October Deborah Giannecchini was awarded $70.075 million in compensatory and punitive damages. In May Gloria ... Read More

Johnson & Johnson reaps profits from allegedly dangerous drugs

Johnson & Johnson is swimming in profits. The company announced its 2016 second quarter results that shows sales of $18.5 billion, an increase of 3.9 percent over 2015 second quarter. “We continue to see good momentum through the first half of 2016, delivering solid results in the second quarter, supported by strong underlying growth across our enterprise,” said Alex Gorsky, Chairman and Chief Executive Officer. “We saw notable strength in our Pharmaceuticals business due to the continued success of new products, and also achieved significant clinical milestones, advancing our robust pipeline.” Johnson & Johnson increased its sales guidance for the ... Read More

Johnson & Johnson ordered to compensate victims of Risperdal-induced gynecomastia

Johnson & Johnson suffered a significant blow last week when a Philadelphia jury slapped the consumer health care giant with a $70 million judgment over claims that its antipsychotic drug Risperdal caused an adolescent boy to grow female breasts. “The cases are not going away, and as the losses mount, J&J must also deal with its image, which has been tarnished from this ongoing saga,” BioPharma Dive reported. “To make matters worse, J&J is also facing numerous lawsuits alleging a link between the company’s talcum powder and ovarian cancer.” The company has already been slapped with back-to-back judgments in those ... Read More

Johnson & Johnson slapped with back-to-back multimillion dollar verdicts linked to Risperdal, talc products

Six months after two trials resulting in multi-million dollar verdicts against Johnson & Johnson – including $112 million in punitive damages – for claims linking ovarian cancer to the genital use of its talcum powder products, the consumer health care giant was slapped with another multimillion verdict, this time by a Philadelphia jury that found the company’s antipsychotic drug Risperdal caused a young boy to grow female breasts. In all three cases, plaintiffs accused Johnson & Johnson of knowing the risks associated with its products but failed to warn the public, another classic example of Big Pharma putting profits before ... Read More

Johnson & Johnson litigation: Is talc the next asbestos?

In the wake of last week’s huge legal defeat for Johnson & Johnson, the second this year alleging that the company’s iconic product, talc-containing Baby Powder, causes ovarian cancer, Law360 assessed the current climate in the talc ovarian cancer litigation and asked various experts to make predictions. The publication reports that experts say the true significance of these huge verdicts, the first a $72 million verdict in February and then a $55 million verdict May 2, both in favor of the plaintiffs, has yet to be determined. Johnson & Johnson has said that it will appeal both verdicts. Russell J. Jackson, an adjunct professor who teaches product liability ... Read More

Experts wonder why Johnson & Johnson refused to abandon talc in Baby Powder

It isn’t a new thing for Johnson & Johnson to continue to espouse the safety of chemicals that have become so questionable the company removed them from its products  – things like formaldehyde, parabens, phthalates, and triclosan. “In every case, J&J states that the chemicals haven’t been proven harmful or that they were used in small enough amounts to be safe, but the company decided to remove them from its products anyway,” a recent article published by Bloomberg reports. The article quotes Johnson and Johnson’s website: “For phthalates, the company says it recognizes that ‘the best way to keep your confidence was not to ... Read More

Johnson & Johnson still profiting despite losing personal injury lawsuits

Johnson & Johnson has been slammed with litigation, paying millions to plaintiffs claiming they were injured by the company’s products. But those hits are not enough to keep several brokerages from upgrading the ratings for Johnson & Johnson stock. Goldman Sachs, for example, recently changed its prognosis to “neutral” after holding it at “sell” for 14 months. But the company’s luck may eventually run out. On Feb. 22, a state jury in Missouri slapped the company with a $72 million verdict in a lawsuit that blamed the company’s talcum power products for causing a woman’s ovarian cancer death. Johnson & ... Read More

Beasley Allen fights for victims harmed by Johnson & Johnson products

Johnson & Johnson on its website claims that it is “caring for the world, one person at a time,” but recent verdicts against the multi-billion-dollar-earning multinational medical devices, pharmaceutical and consumer packaged goods manufacturer suggest the company is more interested in putting profits before patients. This week, a federal jury in Dallas awarded five plaintiffs a total of $467.6 million in a lawsuit that blamed Johnson & Johnson’s DePuy Orthopedics’ metal-on-metal hip implant for injuries including metal poisoning and revision surgeries. The verdict comes just weeks after a St. Louis jury awarded $72 million to the survivors of Jacqueline Fox, who sued ... Read More

Jury finds Johnson & Johnson liable for ovarian cancer death linked to talcum powder; $72 million verdict

On Monday a St. Louis jury ordered Johnson & Johnson to pay $72 million to the family of deceased plaintiff Jacqueline Fox, who alleged the company’s talc-containing products contributed to the development of her ovarian cancer. Fox died at age 62 just before the trial began. She had been using Johnson’s Baby Powder and Shower to Shower body powder for feminine hygiene for more than 35 years. Shower to Shower in particular was marketed by Johnson and Johnson for feminine hygiene with the memorable slogan “Just a sprinkle a day helps keep odor away.” When the company introduced the slogan in the ... Read More